Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oramed Pharmaceuticals In...

    NASDAQ: ORMP · Real-Time Price · USD
    2.12
    -0.12 (-5.36%)
    At close: Jun 13, 2025, 3:59 PM
    2.12
    0.00%
    After-hours: Jun 13, 2025, 04:04 PM EDT

    Oramed Pharmaceuticals Statistics

    Share Statistics

    Oramed Pharmaceuticals has 40.85M shares outstanding. The number of shares has increased by -0.78% in one year.

    Shares Outstanding

    n/a
    		 40.85M

    Shares Change (YoY)

    n/a
    		 -0.78%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 18.77%

    Shares Floating

    n/a
    		 32.77M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,336

    FTD / Avg. Volume

    n/a
    		 3.36%

    Short Selling Information

    The latest short interest is 489.42K, so 1.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 489.42K

    Short % of Shares Out

    n/a
    		 1.2%

    Short % of Float

    n/a
    		 1.32%

    Short Ratio (days to cover)

    n/a
    		 5.76

    Valuation Ratios

    The PE ratio is 16.86 and the forward PE ratio is -1.77. Oramed Pharmaceuticals's PEG ratio is -0.15.

    PE Ratio

    n/a
    		 16.86

    Forward PE

    n/a
    		 -1.77

    PS Ratio

    n/a
    		 69.5

    Forward PS

    n/a
    		 110.8

    PB Ratio

    n/a
    		 0.57

    P/FCF Ratio

    n/a
    		 -8.83

    PEG Ratio

    n/a
    		 -0.15
    Financial Ratio History

    Enterprise Valuation

    Oramed Pharmaceuticals has an Enterprise Value (EV) of 135.69M.

    EV / Sales

    n/a
    		 101.26

    EV / EBITDA

    n/a
    		 -8.71

    EV / EBIT

    n/a
    		 -13.18

    EV / FCF

    n/a
    		 -12.86

    Financial Position

    The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 3.06

    Quick Ratio

    n/a
    		 3.06

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 -3.31

    Debt / FCF

    n/a
    		 -4.89

    Interest Coverage

    n/a
    		 -4.4

    Financial Efficiency

    Return on Equity is 3.37% and Return on Invested Capital is -7.21%.

    Return on Equity

    n/a
    		 3.37%

    Return on Assets

    n/a
    		 2.51%

    Return on Invested Capital

    n/a
    		 -7.21%

    Revenue Per Employee

    n/a
    		 $103,076.92

    Profits Per Employee

    n/a
    		 $425,000

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -5.78% in the last 52 weeks. The beta is 1.62, so Oramed Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.62

    52-Week Price Change

    n/a
    		 -5.78%

    50-Day Moving Average

    n/a
    		 2.22

    200-Day Moving Average

    n/a
    		 2.32

    Relative Strength Index (RSI)

    n/a
    		 41.73

    Average Volume (20 Days)

    n/a
    		 69,600

    Income Statement

    In the last 12 months, Oramed Pharmaceuticals had revenue of 1.34M and earned 5.53M in profits. Earnings per share was 0.14.

    Revenue

    n/a
    		 1.34M

    Gross Profit

    n/a
    		 1.34M

    Operating Income

    n/a
    		 -15.77M

    Net Income

    n/a
    		 5.53M

    EBITDA

    n/a
    		 -15.57M

    EBIT

    n/a
    		 7.13M

    Earnings Per Share (EPS)

    n/a
    		 0.14
    Full Income Statement

    Balance Sheet

    The company has 9.05M in cash and 51.62M in debt, giving a net cash position of -42.57M.

    Cash & Cash Equivalents

    n/a
    		 9.05M

    Total Debt

    n/a
    		 51.62M

    Net Cash

    n/a
    		 -42.57M

    Retained Earnings

    n/a
    		 -157.56M

    Total Assets

    n/a
    		 165.08M

    Working Capital

    n/a
    		 137.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.29M and capital expenditures -254K, giving a free cash flow of -10.55M.

    Operating Cash Flow

    n/a
    		 -10.29M

    Capital Expenditures

    n/a
    		 -254K

    Free Cash Flow

    n/a
    		 -10.55M

    FCF Per Share

    n/a
    		 -0.26
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1176.79% and 412.31%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1176.79%

    Pretax Margin

    n/a
    		 379.7%

    Profit Margin

    n/a
    		 412.31%

    EBITDA Margin

    n/a
    		 -1162.16%

    EBIT Margin

    n/a
    		 -1176.79%

    FCF Margin

    n/a
    		 -787.24%

    Dividends & Yields

    ORMP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 5.93%

    FCF Yield

    n/a
    		 -11.33%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ORMP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 3.54

    Graham Upside

    n/a
    		 66.98%

    Stock Splits

    The last stock split was on Jan 23, 2013. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Jan 23, 2013

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 5.8

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist